Navigation Links
Ventas Appoints James D. Shelton and Robert D. Reed to Board
Date:3/5/2008

's properties and the Company's ability to timely and fully realize the expected revenues and cost savings therefrom; (q) factors causing volatility in the Company's revenues generated by its seniors housing communities managed by Sunrise Senior Living, Inc. ("Sunrise"), including without limitation national and regional economic conditions, costs of materials, energy, labor and services, employee benefit costs and professional and general liability claims; (r) the movement of U.S. and Canadian exchange rates; (s) year-over-year changes in the Consumer Price Index and the effect of those changes on the rent escalators, including the rent escalator for Master Lease 2 with Kindred, and the Company's earnings; (t) the impact on the liquidity, financial condition and results of operations of the Company's operators, tenants, borrowers and managers, as applicable, resulting from increased operating costs and uninsured liabilities for professional liability claims, and the ability of the Company's operators, tenants, borrowers and managers to accurately estimate the magnitude of such liabilities; and (u) the impact of the Sunrise strategic review process and accounting, legal and regulatory issues. Many of these factors are beyond the control of the Company and its management.

Contacts: Debra A. Cafaro

Chairman, President and CEO

or

Richard A. Schweinhart

Executive Vice President and CFO

(502) 357-9000


'/>"/>
SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas to Present at the Citi 2008 Global Property CEO Conference
2. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
3. Ventas Completes Previously Announced Sale of Common Stock
4. Ventas Enters Agreement to Sell Common Stock
5. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Ventas Appoints Brush SVP - Senior Housing Development and Operations
8. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
9. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
10. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
11. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...h a pound of cure.' -Henry de Bracton – A disea...cause the deepest anguish is preventable. It is no...entable. Sunday, 4 February 2007, is World Cancer ...ying the theme - “Today’s Children, Tomorrow’s Wor...
... loss of muscle tone in the body, which occurs dur...r or anger. Cataplexy is one of the symptoms of// ... asleep. In narcolepsy there are compulsive sleep...tible urge to sleep even in the most unlikely circ...
...nt sports in the world, has continued to grow in p...hildren participating in organized and// unorganiz... children at risk for injury. A study conducted by...d Policy (CIRP) at Columbus Children’s Hospital is...
...new weapon is being investigated.// Scientists ha...nt -oligo fructose, on obese human subjects. The...ural fiber seen in baby foods, cereals and yogurt ... on genetically obese lab rats. Reportedly, oligo...
Other Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:Cataplexy During Status Cataplecticus Resembles REM Sleep 2Health News:Study Reveals 1.6 Million Pediatric Soccer Injuries 2
(Date:11/20/2008)...-FirstCall/ -- PAREXEL International Corporation (...al services provider, today announced that it has ...ry consulting and clinical research capabilities. ...has locations throughout five important biopharmac...de Argentina, Brazil, Chile, and Mexico. This expa...
(Date:11/19/2008)...chieve statistical significance , , ISELIN,...Corporation (Nasdaq: PARS ) today announced resu...l NanoEmulsion (NE) drug delivery technology formu... The multi-center, randomized, double-blinded, pl...ficacy of the Company,s 3% Diclofenac Diethanolami...
(Date:11/19/2008)...t from Roche- , , MONTVALE, N.J., Nov. 19 /...rp. (Nasdaq: MEMY ) today announced that it has ... of R3487/MEM 3454, its lead alpha-7 nicotinic rec...with schizophrenia (CIAS). The Company has random... a $5.0 million payment from its partner Roche. M...
(Date:11/18/2008)...Newswire-USNewswire/ -- Forty-two leading U. S. sc...tional forum to consider cutting-edge innovations ...al economy from outbreaks of dangerous zoonotic di... Among those innovations: , , , , ...le that detects highly contagious and dangerous zo...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 1Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 2Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 3Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 4Providing toilets safe water is top route to reducing world poverty 3A UN University 5450 5iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 1iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 2iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers 8359 3Antibiotics May Not Cause Diarrheal Bacteria 27262 1Antibiotics May Not Cause Diarrheal Bacteria 27262 2Healthcare Resources Available in Difficult Times 27258 1Healthcare Resources Available in Difficult Times 27258 2Healthcare Resources Available in Difficult Times 27258 3
...Mass.--(BUSINESS WIRE)--Jun 8, 2007 - Archemix Cor... and developing,aptamers, announced the successful...r therapeutic, ARC1779. ARC1779 is designed to,sel...ation of,platelets by inhibiting the binding of vo...platelets. Activated vWF is scientifically,recogni...
...MARGIN: 0in 0in 0pt; LINE-HEIGHT: 150%; mso-hyphen...oneering nasal spray,could stop thousands of patie...t was reported today1 at the 10th Congress of,the ..., 7–9,June. The study investigated whether t... fast onset of pain relief and short,duration of e...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: